AMEX · NRXS
NeurAxis, Inc.
$7.55-$0.02 (-0.26%)
NeurAxis, Inc.’s quoted price sits in the upper half of its reported 52-week range, 19.08% below the high.
Loading market information…
AMEX · RVP · USD
Stock price, earnings
Quote as of Oct 29, 2026, 07:56 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Retractable Technologies, Inc.’s quoted price sits in the lower half of its reported 52-week range, 37.67% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Retractable Technologies, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Retractable Technologies, Inc. is a medical device company focused on the innovation, production, and sale of secure medical instruments, predominantly syringes, for the healthcare sector. Their reach extends across the United States, the broader North and South American continents, and other international territories. The company's diverse product range includes a variety of safety-engineered items such as VanishPoint insulin, tuberculin, and allergy antigen syringes, as well as Patient Safe syringes and Luer Caps. They also offer small diameter tube adapters, blood collection tube holders, allergy trays, and IV safety catheters. Further offerings feature VanishPoint blood collection sets, EasyPoint needles, and VanishPoint autodisable syringes. Distribution of these products occurs through a combination of general and specialized distributors, international partners, and a dedicated direct sales network. Founded in 1994, the company's main operations are headquartered in Little Elm, Texas.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:22 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$7.55-$0.02 (-0.26%)
NeurAxis, Inc.’s quoted price sits in the upper half of its reported 52-week range, 19.08% below the high.
$8.80+$0.38 (+4.51%)
Harvard Bioscience, Inc.’s quoted price sits in the upper half of its reported 52-week range, 6.38% below the high.
$3.86-$0.09 (-2.28%)
SCYNEXIS, Inc.’s quoted price sits in the lower half of its reported 52-week range, 57.68% below the high.
$1.36-$0.06 (-3.9%)
Femasys Inc.’s quoted price sits in the lower half of its reported 52-week range, 93.9% below the high.
$4.40+$0.45 (+11.39%)
CollPlant Biotechnologies Ltd.’s quoted price sits in the lower half of its reported 52-week range, 80.79% below the high.
$0.93-$0.08 (-8.04%)
Exicure, Inc.’s quoted price sits in the lower half of its reported 52-week range, 90.14% below the high.
$2.13-$0.23 (-9.75%)
NeuroSense Therapeutics Ltd.’s quoted price sits in the lower half of its reported 52-week range, 91.61% below the high.
$3.88-$0.15 (-3.72%)
NEXGEL, Inc.’s quoted price sits in the lower half of its reported 52-week range, 92.76% below the high.
